Before a pill reaches your pharmacy, it's been tested dozens of times. Is it pure? Is it sterile? Will it degrade in the bottle? The pharmaceutical quality control market report by MRFR shows that chemical testing is the largest testing type, but microbiological testing is the fastest‑growing. The market is $2.54 billion and will hit $6.32 billion by 2035, growing at 8.59% CAGR. Why the surge? Because regulators are cracking down, and one contaminated batch can bankrupt a company.

What's driving growth? Laboratory equipment is the largest product type, but software solutions are the fastest‑growing. The pharmaceutical quality control market analysis highlights that chromatography is the dominant technology, but mass spectrometry is the fastest‑growing — because it's incredibly sensitive at detecting trace impurities.

What's new? Automated quality control systems that use AI to flag out‑of‑specification results in real time. And portable testing devices that allow QC on the manufacturing floor, not just in the lab.

The bottom line: QC is not a cost center — it's an insurance policy. Without it, the next thalidomide could be sitting on your shelf.